Relationship between HbA1c and hypoglycaernia in type 2 diabetes patients treated with prandial plus basal insulin mixture or basal insulin regimens

被引：0
|
作者：
Chan, J.
Frier, B. M.
Leyk, M.
Jones, C. A.
Tan, M. H.
机构：
[1] Eli Lilly & Co, Indianapolis, IN 46285 USA
[2] Univ Edinburgh, Royal Edinburgh Infirm, Dept Diabet, Edinburgh EH10 5HF, Midlothian, Scotland
来源：
DIABETOLOGIA | 2007年 / 50卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
0984
引用
收藏
页码：S407 / S407
页数：1
相关论文
共 50 条
  • [31] Levels of FPG and HbA1c Control and the Relationship to BMI in T2D Patients Treated With Basal Insulin and OAD Therapy
    Colclough, Hayley A.
    Piercy, James
    Benford, Mike
    [J]. DIABETES, 2012, 61 : A609 - A609
  • [32] Meta-analysis of Efficacy and Safety Outcomes Associated With the Basal-Plus Regimen of Insulin Glargine and Insulin Glulisine among Type 2 Diabetes Patients With HbA1c≥8%
    Raccah, Denis
    Lin, Jay
    Bahloul, Amar
    Wang, Edward
    Penfornis, Alfred
    [J]. DIABETES, 2012, 61 : A620 - A620
  • [33] The relationship between HbA1c and hypoglycaemia in patients with diabetes treated with insulin degludec versus insulin glargine 100 units/mL
    Jones, Karen L.
    Huynh, Lian Q.
    Hatzinikolas, Seva
    Rigda, Rachael S.
    Phillips, Liza K.
    Pham, Hung T.
    Marathe, Chinmay S.
    Wu, Tongzhi
    Malbert, Charles H.
    Stevens, Julie E.
    Lange, Kylie
    Rayner, Christopher K.
    Horowitz, Michael
    [J]. DIABETES OBESITY & METABOLISM, 2020, 22 (05): : 788 - 797
  • [34] Prandial premixed insulin analogue regimens versus basal insulin analogue regimens in the management of type 2 diabetes: An evidence-based comparison
    Ilag, Liza L.
    Kerr, Lisa
    Malone, James K.
    Tan, Meng H.
    [J]. CLINICAL THERAPEUTICS, 2007, 29 : 1254 - 1270
  • [35] Prandial Options to Advance Basal Insulin Glargine Therapy: Testing Lixisenatide Plus Basal Insulin Versus Insulin Glulisine Either as Basal-Plus or Basal-Bolus in Type 2 Diabetes: The GetGoal Duo-2 Trial
    Rosenstock, Julio
    Guerci, Bruno
    Hanefeld, Markolf
    Gentile, Sandro
    Aronson, Ronnie
    Tinahones, Francisco J.
    Roy-Duval, Christine
    Souhami, Elisabeth
    Wardecki, Marek
    Ye, Jenny
    Perfetti, Riccardo
    Heller, Simon
    [J]. DIABETES CARE, 2016, 39 (08) : 1318 - 1328
  • [36] Report between measures of glycemia and HbA1c in diabetic patients of type 2 treated by insulin
    Pechtner, V.
    Cueille, C.
    Choi, S.
    Shrom, D.
    Iiag, L.
    [J]. DIABETES & METABOLISM, 2009, 35 : A74 - A74
  • [37] Mealtime 50/50 basal plus prandial insulin analogue mixture with a basal insulin analogue, both plus metformin, in the achievement of target HbA1c and pre- and postprandial blood glucose levels in patients with type 2 diabetes:: A multinational, 24-week, randomized, open-label, parallel-group comparison
    Robbins, David C.
    Beisswenger, Paul J.
    Ceriello, Antonio
    Goldberg, Ronald B.
    Moses, Robert G.
    Pagkalos, Emmanuil M.
    Milicevic, Zvonko
    Jones, Cate A.
    Sarwat, Samiha
    Tan, Meng H.
    [J]. CLINICAL THERAPEUTICS, 2007, 29 (11) : 2349 - 2364
  • [38] Prandial-basal insulin regimens plus oral antihyperglycaemic agents to improve mealtime glycaemia: initiate and progressively advance insulin therapy in type 2 diabetes
    Jain, S. M.
    Mao, X.
    Escalante-Pulido, M.
    Vorokhobina, N.
    Lopez, I.
    Ilag, L. L.
    [J]. DIABETES OBESITY & METABOLISM, 2010, 12 (11): : 967 - 975
  • [39] Once weekly basal insulin Fc is safe and efficacious in patients with type 2 diabetes previously treated with basal insulin
    Frias, J.
    Chien, J.
    Zhang, Q.
    Chigutsa, E.
    Landschulz, W.
    Wullenweber, P.
    Haupt, A.
    Kazda, C.
    [J]. DIABETOLOGIA, 2021, 64 (SUPPL 1) : 72 - 72
  • [40] Effect of Internet Therapeutic Intervention on HbA1c Levels in Patients with Type 2 Diabetes Treated with Insulin
    Tildesley, Hugh D.
    Mazanderani, Adel B.
    Ross, Stuart A.
    [J]. DIABETES, 2010, 59 : A134 - A135
12345